Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q3 2025 value amounting to 0.35%.

  • Agios Pharmaceuticals' Return on Capital Employed changed 0.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.35% for FY2024, which is 300.0% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Return on Capital Employed of 0.35% as of Q3 2025, which was down 0.0% from 0.32% recorded in Q2 2025.
  • Agios Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.17% for Q2 2021, and its period low was 0.54% during Q2 2024.
  • In the last 5 years, Agios Pharmaceuticals' Return on Capital Employed had a median value of 0.33% in 2023 and averaged 0.33%.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Return on Capital Employed surged by 2500bps in 2021, and later tumbled by -1900bps in 2024.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.26% in 2021, then dropped by -28bps to 0.34% in 2022, then fell by -28bps to 0.43% in 2023, then surged by 40bps to 0.26% in 2024, then plummeted by -36bps to 0.35% in 2025.
  • Its Return on Capital Employed was 0.35% in Q3 2025, compared to 0.32% in Q2 2025 and 0.28% in Q1 2025.